Unknown

Dataset Information

CITN-06: a Phase I/expansion trial of alt-803, an IL-15 superagonist, in patients with advanced melanoma


ABSTRACT:

SUBMITTER: Margolin K 

PROVIDER: S-EPMC4288745 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature